Number 29, 2006 Bypass surgery for coronary artery disease: a vanishing treatment?
Value of perioperative transesophageal echocardiography
Back to the Summary
Otto Kamp
Department of Cardiology, Institute for Cardiovascular Research VU, VU University Medical Center, Amsterdam, The Netherlands
Correspondence: Dr Otto Kamp, Department of Cardiology, Institute for Cardiovascular Research VU, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. Tel: +31 20 444 2244; fax: + 31 20 444 2446; e-mail: o.kamp@vumc.nl
| Abstract
At present, transesophageal echocardiography (TEE) is a powerful diagnostic modality in the perioperative setting. The assessment of regional and global myocardial function is the most important clinical application. Furthermore, TEE in combination with stress (atrial pacing, pharmacologic stress, volume loading) provides important additional information about myocardial ischemia, myocardial viability, and dynamic mitral regurgitation. Assessment of native valve function and repair, especially of the mitral valve, has been common clinical practice, improving the outcome of valvular repair in many surgical centers. Recent progress in transducer technology and computerized image processing also brings three-dimensional and contrast-enhanced TEE closer to the operating room. Finally, miniaturization of probes and automated contour detection techniques make TEE a sensitive and continuous monitor of global and segmental left ventricular function. This review will focus on novel emerging and innovative technologies in TEE for perioperative evaluation.
Keywords:
Transesophageal echocardiography, stress echocardiography, 3-dimensional echocardiography, contrast echocardiography, automated border detection, perioperative care
|
Introduction
Transesophageal echocardiography (TEE) has evolved rapidly since its initial use in the 1970s [1,2] until, today, it is increasingly gaining popularity for the anatomical and hemodynamic evaluation of patients in the perioperative setting. Common indications for the technique are summarized in Table I. Stress TEE using atrial pacing, pharmacologic stress, or volume loading is potentially available for the patient treated with a respirator, for detection of myocardial ischemia and for evaluation of dynamic mitral regurgitation. Recent advances in ultrasound instrumentation and computer technology have led to dynamic 3-dimensional echocardiography, thus introducing a new era in cardiovascular imaging. Furthermore, evolution in the field of contrast echocardiography, using contrast agents capable of pulmonary passage, can further enhance diagnostic imaging and might bring myocardial contrast echocardiography to the operating room. Developments in quantification techniques, together with miniaturization of the probes, will allow continuous monitoring of the patient in the perioperative setting. Selection of the particular TEE examination should therefore be tailored to clinical circumstances.
Table I. Common indications for transesophageal echocardiography in the perioperative setting.
Perioperative monitoring of myocardial ischemia
Perioperative applications of TEE enable continuous monitoring of surgical procedures without disturbing the sterile field of work, thus allowing for the noninvasive evaluation of regional and global left ventricular function (Figure 1). In addition, the technique can accurately identify new regional wall motion abnormalities as markers of myocardial hypoperfusion before and immediately after bypass.
Figure 1. Short-axis (SAx) transgastric view at 0° of the mid-segments of the left ventricle, providing insight into the efficiency of coronary perfusion in all three coronary distribution areas, thus giving immediate information on global and regional systolic left ventricular function. Epicardial contours are drawn on the left; endocardial contours on the right.
During surgery, several nonischemic mechanisms may modify the left ventricular contractile function, either directly or through changes in position of the heart within the thorax. The most important cause of nonischemic alteration of segmental wall motion abnormalities is represented by opening of the thoracic cavity or pericardium, or both, which can modify the movement of the interventricular septum from a reduced systolic motion towards a clear paradoxical movement. The interpretation of the septum motion can also be confounded by discoordinated patterns of contraction caused by bundle branch block or ventricular pacing. However, when the septum is viable, it thickens appreciably during systole.
Segmental hypokinesis represents the majority of transient segmental wall motion abnormalities, but it has been shown that hypokinetic segments have the greatest mismatch between perfusion and contraction. Therefore, not all segmental wall motion abnormalities are indicative of myocardial ischemia. However, a sudden decrease in segmental contraction by a reduction in myocardial thickening is almost certainly the result of myocardial ischemia. Tissue Doppler imaging is a promising technique for quantifying myocardial ischemia and viability. It estimates circumferential or longitudinal velocities of the moving myocardium by detecting the phase shifts of ultrasound signals reflected by myocardial tissue. Alterations in systolic and diastolic velocities and isovolumetric relaxation time during acute myocardial ischemia can thus be assessed [3].
Assessment of native valve function and repair
Transesophageal echocardiography provides information of greatest value in mitral reconstructive surgery. The pathomorphology of the diseased valve and subvalvular apparatus can be clearly defined by TEE, which may have an important impact on the feasibility of surgery and the surgical strategy during operation. This is of importance in surgical correction of mitral regurgitation, because valve repair has been shown to be more beneficial than valve replacement, and to improve long-term survival.
Decisions based on TEE findings made at the time of operation may affect both early and late survival, and the need for reoperation or replacement of the valve during operation. In this respect, 3-dimensional TEE may become more and more important. 3-Dimensional echocardiography displays a bird's-eye view of the mitral valve, either looking down from the left atrium or looking up from the left ventricle. Thus 3-dimensional reconstruction allows spatial perception of all integrated components of the mitral valvular complex, such as the atrioventricular orifice and leaflets (Figure 2). In patients with mitral valve regurgitation, 3-dimensional echocardiography allows detailed visualization of mobility, the coaptation zone, the extent of prolapse, perforation, erosion, retraction, and restriction of valve leaflets [4–6].

Figure 2. 3-Dimensional reconstruction in a patient with mitral valve prolapse of the anterior mitral leaflet (scallop A1), looking from the left atrium down (unroofed left atrium view). (a) Systole, (b) Diastole. Ao, aorta; LAA, left atrial appendage.
Evaluation of endocarditis
Transesophageal echocardiography is abnormal in endocarditis, with the demonstration of either a vegetation-like mass (Figure 3) or a lesion that frequently or almost always results from the endocarditis process such as an abscess (echolucent space), leaflet perforation (Figure 4), fistula, prosthetic valve dehiscence, and paravalvular regurgitation. TEE is the most sensitive technique for the diagnosis of endocarditis, with a sensitivity of approximately 90%. Further diagnostic improvements might be obtained using 3-dimensional echocardiography, revealing complications of endocarditis by views in any plane, including the surgeon's view. The immense diagnostic potential of TEE, especially in the setting of infective endocarditis, has led to a revision of the diagnostic criteria to include echocardiographic findings as a major diagnostic criterion.
Figure 3. 3-Dimensional reconstruction in a patient showing several (three) small mass lesions (vegetations), looking from the aorta ascendens down. (a) Diastole, (b) Systole.
Figure 4. 3-Dimensional view from the aortic valve, looking from the aorta ascendens down (en face view). (a) A leaflet perforation is indicated with an arrow (black hole); the mass lesion with an asterisk. (b) 2-Dimensional color flow image with turbulence in the vena contracta, indirectly demonstrating the perforation site. (c) 2-Dimensional long-axis view, showing significant aortic regurgitation as a result of the perforation of the aortic valve.
Investigation of cardiac masses
Transesophageal echocardiography has been shown to be superior to transthoracic echocardiography for visualization of left atrial thrombi, aortic atheroma and other cardiac thrombi, tumors (Figure 5), or vegetations, as possible sources of cardiac embolism. In this respect, the value of 3-dimensional echocardiography has yet to be determined, but is promising [7].
Figure 5. (a) Volume-rendered 3-dimensional display of a left atrial myxoma. The connection to the lower atrial septum can be seen. (b) Corresponding 2-dimensional image, without evidence of any connection.
Aortic atheromas are also an important cause of stroke during open heart surgery. The increasing number of elderly patients with severe atheromatous disease of the aorta has focused clinical interest on management of severe atheroma of the ascending aorta and the associated risk of intraoperative embolization. Intraoperative TEE provides unique information on the localization and composition of aortic atheroma that may alter the conduct of the operation, especially with regard to the site of cross clamping of the aorta. If atheromas are detected in the arch or in the ascending aorta, the intraoperative stroke rate is significantly increased compared with that in patients without atheroma.
Stress transesophageal echocardiography
In patients in the perioperative setting, stress TEE using atrial pacing, dobutamine, or volume loading offers a valuable extension of its diagnostic ultrasound capabilities. In this regard, we evaluated the capability of simultaneous TEE and atrial pacing [8]. The technique had a high accuracy and diagnostic yield in assessing myocardial ischemia, multivessel disease, and ischemic mitral regurgitation [9]. Alternatively, dobutamine and dipyridamole may be used in TEE [8–11], see also Table II.
Table II. Sensitivity and specificity of stress transesophageal echocardiography for detection of coronary artery disease (ischemia) or myocardial viability.
Potential indications for stress TEE are evaluation of myocardial ischemia in patients with a nondiagnostic transthoracic window, ambiguous results from different tests, accurate measurement of myocardial viability, ‘unexplained’ heart failure, evaluation of dynamic mitral regurgitation, measurement of coronary flow reserve, and distribution of myocardial perfusion using intravenous contrast agents.
In addition, TEE is a method of distinguishing viable from nonviable myocardium. Contractile reserve is consistent with myocardial viability and characterized by baseline wall motion abnormalities that improve with low-dose dobutamine. Perioperative stress echocardiography holds promise as a technique that may differentiate ischemic from nonischemic dysfunction, and enhances therapeutic rationalization when low-output syndromes are treated.
Contrast-enhanced transesophageal echocardiography
The appearance of a myocardial ‘blush’ after contrast injections into the coronary arteries triggered the development of myocardial contrast echocardiography as a means of noninvasive assessment of myocardial perfusion [12]. Importantly, simultaneous assessment of regional anatomy and perfusion and of function, together with the ability to perform serial measurements with a high degree of spatial and temporal resolution became possible (Figure 6). With the advent of new and more stable (second-generation) transpulmonary contrast agents, in addition to important improvements in imaging techniques (such as second-harmonic imaging), visually detectable myocardial contrast can be produced via the intravenous route. Second-harmonic TEE probes are now available and are important for the assessment of myocardial contrast. Alternatively, intra-aortic (or intracoronary) contrast injections using a pigtail catheter in the operating room or critical care unit and second-harmonic TEE might potentially be useful to diagnose perfusion of specific myocardial areas in the setting of patients treated acutely with a respirator [13]. Absence of perfusion, defined as reduced opacification of myocardial segment(s) after a contrast injection, predicts morbidity (heart failure) and absence of viability in that area. In a perioperative setting, myocardial contrast echocardiography has been found to be helpful in determining the adequacy of cardioplegia solution; it also identified a group of patients with significantly worse postoperative outcome in terms of need for inotropic support [14].

Figure 6. Transthoracic apical four-chamber view using harmonic imaging. (a) In the ventricular phase, only the left ventricular cavity is opacified; the myocardium is dark. (b) In the perfusion phase, the myocardium is enhanced by contrast (white).
Monitoring global left ventricular function
Newly commercially available automatic border detection systems can be used in combination with TEE monitoring. Acoustic Quantification (Philips, Andover, Massachusetts, USA) uses the difference in backscatter between blood and myocardium, thus facilitating quantitative description of the endocardial boundaries [15]. During continuous monitoring, within a selected region of interest, several cross-sectional areas (using video frames: 30 frames per second) from a short-axis cross-sectional view of the left ventricle are provided, in addition to plots of derived variables such as the fractional area change and rate of change of area versus time (Figure 1). Limitations of this automatic border detection system are the facts that papillary muscles are presented outside the cross-sectional areas and that no epicardial border detection can be performed, and the technique is thus not helpful in estimating left ventricular wall thickness. However, a load-independent measure of contractility in real-time from TEE monitoring and peripheral pressure can be obtained [15]. Because Acoustic Quantification is a pixel-classification technique rather than a true contour detection, only overall blood area can be calculated, not regional wall motion. Using minimum-cost contour tracking with cardiac management systems (ECHO-CMS) (MEDIS Medical Imaging Systems, Leiden, The Netherlands), continuous, connective, smooth contours allow calculations of regional wall motion, volume estimations, and user corrections. However, at present, this Quantification technique needs an off-line analysis workstation and user interaction [16].
Both Acoustic Quantification and ECHO-CMS are operator dependent and require much practice. The use of intravenous contrast might provide more consistent and reproducible results in the future, enabling appropriate treatment to be initiated without delay.
Conclusion
Developments that are in progress will further influence the perioperative application of TEE. Stress TEE is a realistic option today, 3-dimensional TEE is already commercially available, and second-harmonic TEE has been introduced recently. Despite new developments in computed tomography and magnetic resonance imaging technologies, giving excellent spatial and temporal resolution, the relative low cost, speed, portability, and on-line results of TEE are much in favor of this technique in the management of patients in the perioperative setting. At present, TEE has a major impact on diagnosis in acute and subacute disease states in patients who are hemodynamically compromised. Further developments in automated border detection systems will allow continuous monitoring of the critical care patient, to guide the clinician to appropriate and more timely medical and surgical therapy.
REFERENCES
1. Side CG, Gosling RG.
Non-surgical assessment of cardiac function.
Nature. 1971;232:335–336.
PMID: 5094838 [PubMed - indexed for MEDLINE]
2. Frazin L, Talano JV, Stephanides L, Loeb HS, Kopel L, Gunnar RM.
Esophageal echocardiography.
Circulation. 1976;54:102–108.
PMID: 1277411 [PubMed - indexed for MEDLINE]
3. Derumeaux G, Ovize M, Loufoua J, et al.
Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion.
Circulation. 1998;97:1970–1977.
PMID: 9609091 [PubMed - indexed for MEDLINE]
4. Xin-Fang Wang, Zhi-An Li, Tsung O Cheng, et al. Clinical application of three-dimensional transesophageal echocardiography. Am Heart J. 1994; 128:380–388.
5. Pandian NC, Roelandt J, Nanda NC, et al.
Dynamic three-dimensional echocardiography: methods and clinical potential.
Echocardiography. 1994;11:237–259.
6. Langerveld J, Valocik G, Plokker T, et al.
Additional value of three-dimensional transesophageal echocardiography for patients with mitral valve stenosis undergoing balloon valvuloplasty.
J Am Soc Echocardiogr. 2003;16:841–849.
PMID: 12878993 [PubMed - indexed for MEDLINE]
7. Valocik G, Kamp O, Mihciokur M, et al.
Assessment of the left atrial appendage mechanical function by three-dimensional echocardiography.
Eur J Echocardiogr. 2002;3:207–213.
PMID: 12144840 [PubMed - indexed for MEDLINE]
8. Kamp O, de Cock CC, Funke Kupper AJ, Roos JP, Visser CA.
Simultaneous transesophageal two-dimensional echocardiography and atrial pacing for the detection of coronary artery disease.
Am J Cardiol. 1992;69:1412–1416.
PMID: 1590229 [PubMed - indexed for MEDLINE]
9. Kamp O, de Cock CC, van Eenige J, Visser CA.
Influence of pacing-induced myocardial ischemia on left atrial regurgitant jet: a transesophageal echocardiographic study.
J Am Coll Cardiol. 1994;23:1584–1591.
PMID: 8195518 [PubMed - indexed for MEDLINE]
10. Agati L, Renzi M, Sciomer S, et al.
Transesophageal dipyridamole echocardiography for the diagnosis of coronary artery disease.
J Am Coll Cardiol. 1992;19:765–770.
PMID: 1545071 [PubMed - indexed for MEDLINE]
11. Panza JA, Laurienzo JM, Curiel RV, et al.
Tranesophageal dobutamine stress echocardiography for the evaluation of patients with coronary artery disease.
J Am Coll Cardiol. 1994;24:1260–1267.
PMID: 7930248 [PubMed - indexed for MEDLINE]
12. Kaul S, Senior R, Dittrich H, Raval U, Khattar R, Lahiri A.
Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99m Tc-sestamibi single photon emission computed tomography.
Circulation. 1997;96:785–792.
PMID: 9264483 [PubMed - indexed for MEDLINE]
13. DeMaria AN, Bommer WJ, Riggs K, Keown M, Kwan OL, Mason DT. Echocardiographic visualization of myocardial perfusion by left heart and intracoronary injection of echo contrast agent. Circulation. 1980; 62:III-143. Abstract.
14. Zaroff J, Aronson S, Lee BK, et al.
The relationship between immediate outcome after cardiac surgery, homogeneous cardioplegia delivery, and ejection fraction.
Chest. 1994;106:38–45.
PMID: 8020317 [PubMed - indexed for MEDLINE]
15. Perez JE, Waggoner AD, Barzilai B, Melton HE, Miller JG, Sobel BE.
On-line assessment of ventricular function by automatic boundary detection and ultrasonic backscatter imaging.
J Am Coll Cardiol. 1992;19:313–320.
PMID: 1732358 [PubMed - indexed for MEDLINE]
16. Bosch JG, Reiber JHC, van Burken G, Savalle L, Maurincomme E, Helbing WA.
Automated contour detection and acoustic quantification.
Eur Heart J. 1995;16:35–41.
PMID: 8746936 [PubMed - indexed for MEDLINE]
|